Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. META
2. P
3. ORCL
4. OKTA
5. SPY
6. MGM
7. NVDA
8. MCD
9. GDDY
10. COST

Go back to Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate
(NASDAQ: VALN) Delayed: 6.22 -0.13 (2.05%)
Previous Close $6.35    52 Week High $ 
Open $6.25    52 Week Low $ 
Day High $6.25    P/E N/A 
Day Low $6.08    EPS $ 
Volume 51,759